Table 3.

The primary and secondary endpoints.

	Fenestration (n = 41)	Chimney (n = 42)	p
Initial clinical success, n	37	39	0.973
Primary clinical success, n
Short-term	35	38	0.682
Mid-term	35	38	0.682
Secondary clinical success, n
Short-term	36	38	0.973
Mid-term	36	38	0.973
Endoleak, n
Type I or III	2	1	0.983
Type II	0	2	0.494
Stroke	0	0	N/A
Rupture-free survival, n	38	39	0.984
LSA patency, n	37	38	0.553

LSA, left subclavian artery.